Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Healthcare Innovation Company and the Association for Behavioral Health and Wellness Announce Advancing Behavioral Health and Policy Summit, Dec. 5-6, in Washington, D.C.

Leave a comment


The Healthcare Innovation Company (thINc) and the Association for Behavioral Health and Wellness (ABHW) announced that they will be partnering to produce the Advancing Behavioral Health and Policy Summit in Washington, D.C., December 5-6 at The Watergate Hotel. The Summit is a comprehensive, multi-stakeholder event that focuses on policies, advancements, and collaborations that drive positive change in the equitable access, delivery, and quality of mental health and substance use disorder services.

NEEDHAM, Mass., Sept. 7, 2023 /PRNewswire-PRWeb/ — The Healthcare Innovation Company (thINc) and the Association for Behavioral Health and Wellness (ABHW) announced that they will be partnering to produce the Advancing Behavioral Health and Policy Summit in Washington, D.C. on December 5-6.

Taking place at The Watergate Hotel, the Advancing Behavioral Health and Policy Summit is a comprehensive, multi-stakeholder event that focuses on policies, advancements, and collaborations that drive positive change in the equitable access, delivery, and quality of mental health and substance use disorder services.

“Since the founding of the Association for Behavioral Health and Wellness in 1994, ABHW has been staunch advocates for federal legislative and regulatory policies that help increase access to high-quality mental health and substance use disorder (SUD) care,” said Pamela Greenberg, President and Chief Executive Officer of the Association for Behavioral Health and Wellness. “The Advancing Behavioral Health and Policy Summit is a great opportunity for attendees to engage in thought-provoking conversations and learn about how legislation and regulations can help remove barriers to care, improve crisis response, combat the workforce shortage, promote integrated care models, and ensure people continue to receive the care they need. This Summit provides a place for attendees to dive into and learn about behavioral health policies that ensure everyone who needs it has access to high-quality, affordable mental health and SUD care.”

The Summit is co-located with thINc’s Value-Based Care Summit, which brings together healthcare providers, health plans, pharmaceutical companies/manufacturers, and regulatory and legislative leaders to discuss novel approaches, innovative models, and mutually beneficial partnerships that drive care delivery transformation and accelerate the transition to value-based care.

“This Summit reinforces our mission and belief that elevating the focus on behavioral health services must be an integral element towards the value-based care movement,” said Haritha Krishnarathnam, VP of Strategy and Content, at The Healthcare Innovation Company. “This is a forward-thinking, two-day program that brings together the entire healthcare ecosystem, including, employers, government and public health agencies, and state, local community, and advocacy organizations to discuss major initiatives and the driving forces to advance behavioral health. We are proud to partner with ABHW and look forward to a fantastic, impactful event.”

Both Summits are expected to sell out. Organizations and their teams looking to attend, speak, and sponsor are encouraged to visit https://www.thINc360.com/behavioral to learn more.

About The Healthcare Innovation Company (thINc)
The Healthcare Innovation Company (thINc) creates and produces the world-renowned Healthcare Innovation Congress, thINc360. It also develops content that keeps healthcare, pharma and life sciences executives engaged and informed. By delivering timely content through its live events, webinars, and additional digital offerings, thINc is a catalyst for change for today’s leading organizations, providing them with insights and recommendations to make better business decisions, contain costs, and deliver better results for the populations and markets they serve. Learn more at: https://www.thINc360.com

About the Association for Behavioral Health and Wellness (ABHW)
ABHW is the leading health plan association working to improve access and quality of care for mental health and substance use disorders. ABHW’s members include national and regional health plans who care for more than 200 million people. Together, we work to reduce stigma and advance federal policy on mental health and substance use disorder care. ABHW member companies – Aetna Behavioral Health, Elevance Health, Centene Corporation/Magellan Health, Evernorth, a Cigna company, Kaiser Permanente, Molina Healthcare, New Directions Behavioral Health/Lucet, Optum, and PerformCare, a subsidiary of AmeriHealth Caritas. To learn more, visit https://www.abhw.org and follow us on Twitter at https://twitter.com/ABHWorg and LinkedIn at https://www.linkedin.com/company/association-for-behavioral-health-and-wellness/ 

Media Contact

Reena Joseph, The Healthcare Innovation Company (thINc), +1-781-939-2446, [email protected], https://thinc360.com/vc23004/

SOURCE The Healthcare Innovation Company (thINc)



Health: Abortion

Chicago Nonprofit HACE Launches HACE United Campaign to Raise $100,000 for up to 40 Scholarships

Leave a comment


“As Hispanic Heritage Month begins, we are proud to start this campaign to let our members, board members, supporters, and partners know that investing in the Latino/a/x/e community displays a strong commitment to building the foundation of the next generation of leaders,” said HACE President and CEO Patricia Mota. “Through these scholarships, HACE will provide these young men and women guidance, confidence, skills, and personal and professional development to equip them with tools and knowledge to have successful careers, make a meaningful impact in their communities, and continue a positive legacy that will live for many years.”

HACE supports future leaders through scholarships such as the Dr. Ervin “Vinny” Caraballo Scholarship to continue their education. Caraballo was on HACE’s Board of Directors and was a driving force on the organization’s programming and growing impact Latino/a/x/e community.

HACE also recently created the UIC LARES Olga Camargo scholarship. Named after Olga Camargo, HACE’s chair emeritus and a University of Chicago (UIC) alumna, this scholarship is administered by The Latin American Recruitment and Educational Services (LARES), a premier academic advising, financial aid and educational assistance unit servicing Latino students at the high school and college levels. LARES assists Latino students interested in pursuing higher education with guidance and support.

“Since we launched our scholarship programs, we’ve awarded up to 40 students annually,” Mota said. “Many have said how the scholarships have helped them achieve their dream of attaining a college education, enrolling into a graduate program, and helping make ends meet while they focus on their education. As a benefactor of scholarships myself, I could not have achieved my higher education, and that’s one of the many reasons I give back to my community.”

For more information about donations, visit https://haceonline.org/donate-to-hace/.

About HACE:
The Hispanic Alliance for Career Enhancement (HACE) is a national nonprofit dedicated to the employment, development, and advancement of current and aspiring Latino professionals. Since 1982, HACE has served as a resource for Latinos in the workplace and is a subject matter expert for corporations seeking to access diverse talent. Through professional development, resources, and networks, and by facilitating access to meaningful career opportunities, HACE helps Latinos succeed in every phase of their career. With a network of over 97,000 members across the country, HACE works with employers to remain competitive in an increasingly dynamic economy by helping them attract, develop, and retain Latino and diverse professionals. For information, visit https://www.haceonline.org/about-hace/. 

Media Contact

Marie Lazzara, JJR Marketing, 630-400-3361, [email protected], www.jjrmarketing.com

SOURCE Hispanic Alliance for Career Enhancement

Health: Mental Health

The University of San Francisco School of Nursing and Health Professions Launches New Bachelor of Science in Public Health Program

Leave a comment


The Baccalaureate in Public Health Planning Committee members included Erin Grinshteyn, associate professor; associate dean of Health Professions; Laura Chyu, assistant professor, BSPH and Masters of Public Health (MPH) Program director; Taryn Vian, MPH professor and director of the Community and Public Health Practice and Health Policy Leadership concentrations; Bryan Whaley, professor, Health Studies Director; and Brian Thornton, associate professor.

“I joined BSPH at USF because it conjoins all aspects of health and how they propel and impact each other,” stated student Karima Jalloh. “From environmental health to epidemiology, physiological health, and mental health…the list goes on. This new major is a bridge for those seeking to impact the health of our communities and individuals.”

BSPH student Ashton Green added, “I decided to join the BSPH at USF because I’m trying to understand health care in a more holistic and integrated manner.”

“There was a lot of enthusiasm and energy among students, faculty, and staff at orientation and the first week of classes,” said Laura Chyu, BSPH and MPH program director. “We have a fantastic group of diverse students.”

“The new BS in Public Health is a wonderful opportunity both for our students, who are excited to develop their knowledge and practice in this field, and our communities, which desperately need well-trained public health graduates,” said Erin Grinshteyn, associate dean of Health Professions. “I am so excited to see this major come to fruition here at USF, and I can’t wait to see all the wonderful contributions to the field that our students will make.”

About the USF School of Nursing and Health Professions

The mission of the USF School of Nursing and Health Professions is to improve the health of all populations through equitable and compassionate service, value-driven research, and innovative education of health professionals, preparing them to use their hearts, minds, and souls to change the health of the world. For more information, visit our website.

About the University of San Francisco

The University of San Francisco is a private, Jesuit Catholic university that reflects the diversity, optimism, and opportunities of the city that surrounds it. USF offers more than 230 undergraduate, graduate, professional, and certificate programs in the arts and sciences, business, law, education, and nursing and health professions. At USF, each course is an intimate learning community in which top professors encourage students to turn learning into positive action, so the students graduate equipped to do well in the world — and inspired to change it for the better. For more information, visit usfca.edu.

Media Contact

Kellie Samson, University of San Francisco, 415-601-1915, [email protected], https://www.usfca.edu/

SOURCE University of San Francisco

Health

Antidote joins forces with Beyond Type 1 and JDRF to launch the first-ever Spanish-language clinical trial search engine for type 1 diabetes (T1D)

Leave a comment


“We’re excited to partner with JDRF and Antidote to provide this critical resource for our community, which includes roughly half a million Spanish speakers,” said Beyond Type 1’s VP of Community Programs and Hispanic Relations Mariana Gomez. “At Beyond Type 1, we believe language should never be a barrier that keeps individuals from accessing life-saving diabetes information and tools, and that includes access to information about clinical trials that may be available to them.”

At the time of writing, there are more than 400 type 1 diabetes clinical trials currently looking for patients in the United States, which would necessitate the participation of 2.14 million patients to be fully enrolled. Through the collaboration with Beyond Type 1 and JDRF, Antidote Match™ is now accessible to a larger audience. This breakthrough has the potential to increase trial participation, improve diversity, and foster research findings that are more applicable to individuals in the real world. Patients and caregivers can now visit BeyondType1.org, JDRF.org, and other patient advocacy websites that host Antidote Match™ to choose between an English or Spanish version of the journey when searching for T1D clinical trials. By answering a few health-related questions, they can be matched to trials and view results in their preferred language, opening up new opportunities for Spanish-speaking individuals to engage in diabetes research.

“Advancing care technology and developing treatments and cures through research that will work for everyone living with type 1 diabetes is a top priority for JDRF. This research is not possible without broad and diverse participation in clinical trials,” said Anastasia Albanese-O’Neill, Ph.D., Director of Community Screening and Clinical Trials Education for JDRF. “Integrating Spanish into Antidote Match™ will allow more people to access this clinical trials search engine in their preferred language. This promises to make the platform more inclusive and equitable and increases the likelihood of reaching more members of the type 1 diabetes community.”

The lack of diversity among clinical trial participants has been a long-standing issue in medical research, with well-documented evidence showing that underrepresentation at the study level can lead to inferior health outcomes. In 2022, the FDA took a significant step by issuing guidance to drug, biologic, and medical device manufacturers, urging them to improve the enrollment of participants from underrepresented racial and ethnic populations into clinical trials. The aim of this guidance is to facilitate the development of medications and treatments that are not only effective but also applicable to a broader spectrum of patient populations.

Grace McElroy, VP of Patient Experience & Partnerships at Antidote, expressed Antidote’s commitment to championing the cause of increasing representation in clinical trials. “By breaking down the language barrier for Spanish-speaking patients and caregivers, we aim to connect even more patients with research opportunities that best suit their needs”, she said. “Together, with support from our partners like JDRF and Beyond Type 1, we will offer Spanish search capability across more therapeutic condition areas, especially those that disproportionally impact Hispanic and Latino individuals.”

About Antidote Technologies
Antidote Technologies is a digital health company with a mission to enable faster medical innovation by transforming how sponsors and patients connect. Our precision recruitment approach meets patients where they are, leading to high-quality referrals, reduced site burden, and efficient enrollment. This is made possible by a unique high-tech, high-touch approach, and the largest global partnership network of its kind. We provide patient-centric clinical search technology to hundreds of patient advocacy groups and research foundations, at no cost, to advance medical breakthroughs and increase clinical trial participation. Antidote, formerly known as TrialReach, is based in the US and the UK. For more information, please visit http://www.antidote.me.

About Beyond Type 1
Beyond Type 1 is a global nonprofit dedicated to the diabetes community. We serve the largest digital audience of any diabetes nonprofit, and our mission is to help people living with diabetes to stay alive and thrive. Through peer support programs, global campaigns and digital platforms, Beyond Type 1 is uniting the global diabetes community—across all types—helping to change what it means to live with chronic illness.

About JDRF
JDRF’s mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally and globally for efficiency and broader fundraising impact, and uniting on a global stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement, and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq).

Media Contacts
Kim Pace
Associate Director, Marketing Communications | Beyond Type 1
[email protected]  

Chelsea-Lyn Rudder
Associate Vice President, Public Relations, Media Relations, Celebrity Engagement | JDRF
646-946-0513
[email protected]  

Amanda McDowell
Content Marketing Manager | Antidote
[email protected]  

1. https://www.cdc.gov/media/releases/2017/p0412-diabtes-rates.html
2. https://www.clinicaltrials.gov/search?cond=type%201%20diabetes&aggFilters=status:rec  

Media Contact

Amanda McDowell, Antidote Technologies, 1 8885091308, [email protected], https://www.antidote.me/ 

SOURCE Antidote Technologies

Health

Computer Software Assurance for FDA-Regulated Industries, Upcoming Webinar Hosted by Xtalks

Leave a comment


Understanding the specific scenarios and circumstances where computer software assurance is most beneficial will allow organizations to make informed decisions when it comes to software validation, ultimately ensuring compliance. Attendees will also learn how to maintain the appropriate records to meet FDA requirements to establish appropriate assurance activities and records.

As the regulatory landscape becomes increasingly complex, staying ahead of the curve is crucial. Join this webinar to embrace the future of software compliance and learn how to navigate regulatory requirements more effectively to elevate a company’s success.

Register for the live webinar taking place on Friday, September 29, 2023, at 10am PDT (12pm CDT / 1pm EDT) featuring speakers Kevin Marcial, CSV/CSA Services Manager, Principal Validation Specialist, Performance Validation; and Hemadri Doma, QA Computer System Validation Engineer III, Tolmar Inc.

For more information, or to register for this event, visit Computer Software Assurance for FDA-Regulated Industries.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/ 

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected]

SOURCE Xtalks

Health

Leveraging a Clinical Trial Intelligence Platform, Upcoming Webinar Hosted by Xtalks

Leave a comment


Join this webinar to learn how Lokavant’s Clinical Trial Intelligence Platform helps study teams collect, understand and apply clinical trial data to help study managers make informed decisions to improve clinical trial performance.

Register for the live webinar taking place on Thursday, September 28, 2023, at 10am PDT (12pm CDT / 1 pm EDT) that will feature expert speakers Angela Radcliffe, R&ED Digital Performance Improvement & Innovation, Bristol Myers Squibb; Milind Kamkolkar, Co-Founder & COO, Paradigm; and Andreas Matern, Executive Vice President, Product Development, Lokavant.

For more information, or to register for this event, visit AI in Clinical Trials: Leveraging a Clinical Trial Intelligence Platform.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/ 

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected]

SOURCE Xtalks

Health: Psychology

ASNC Publishes New Model Coverage Policy for Cardiac PET Imaging

Leave a comment


“Unfortunately, some payers are not fully aware of the extensive literature supporting cardiac PET in many clinical scenarios, including the newer indications for evaluating coronary microvascular dysfunction, cardiac sarcoidosis and inflammation, and cardiovascular infection,” says ASNC President Mouaz H. Al-Mallah, MD, MSc, FASNC (Houston Methodist DeBakey Heart and Vascular Center, Texas). “ASNC’s new model coverage policy describes each clinical situation where a cardiac PET study is currently indicated, including symptoms, references and cross-references to the appropriate use criteria.”

The document also provides tables detailing how the clinical indications for cardiac PET correspond to the ICD-10 Clinical Modification codes. In this way, ASNC intends for the model coverage policy to function as a helpful resource for the cardiology community, referring physicians and their billing/coding staff.

“The ASNC Model Coverage Policy: 2023 Cardiac Positron Emission Tomography” was developed by a team of leading authorities in cardiac PET imaging and myocardial blood flow assessment. The writing committee’s co-chairs were Stephen Horgan, MD, PhD (Morristown Medical Center, Morristown, New Jersey), and Rupa Sanghani, MD, FASNC (Rush University Medical Center, Chicago, Illinois).

ABOUT ASNC
The American Society of Nuclear Cardiology and its more than 4,900 members have been improving cardiovascular outcomes through image-guided patient management for more than 30 years. As the only society dedicated solely to the field of nuclear cardiology, ASNC establishes standards for excellence in cardiovascular imaging through the development of clinical guidelines, professional medical education, advocacy and research development. ASNC provides peer-reviewed original articles through its official publication, The Journal of Nuclear Cardiology. For more information, visit http://www.asnc.org. 

Media Contact

Kathy Boyd David, ASNC, 717-422-1181, [email protected], www.asnc.org

Twitter

SOURCE ASNC



Health: Mental Health

DreamLife Recovery Expands Pennsylvania Presence with Opening of PHP Outpatient Facility in Pittsburgh

Leave a comment


Recognizing that comprehensive care is required to treat alcohol and drug addiction, DreamLife Recovery offers integrated programs to serve the needs of each individual patient, from dual diagnosis and trauma-informed care to treat co-occurring disorders, to specialized LGBTQIA+ programs and LIFEOffice programs designed to encourage working professionals to seek the recovery care they need.

“At DreamLife Recovery, we focus on treating the whole person with the medically appropriate care they need, from medical detoxification through aftercare management,” said Brooke McKenzie, chief of clinical care at DreamLife Recovery. “Through our PHP facility, we can provide reality-based therapy, allowing our patients to learn and recover in a setting that is more like their real-life living environment. By teaching skills such as coping mechanisms and budgeting alongside the recovery treatment program, we are able to extend the continuity of care and help our patients achieve lasting recovery.”

Similar to the care provided at DreamLife Recovery’s residential facility, partial hospitalization patients receive structured and concentrated treatment, but within a more flexible environment. With on-site medical staff for comprehensive care and close collaboration with the residential facility, DreamLife Recovery Pittsburgh ensures each patient experiences a seamless continuum of treatment. This comprehensive approach ensures that individuals not only achieve sobriety but also gain the tools necessary for long-term success and overall wellness.

DreamLife Recovery Pittsburgh’s partial hospitalization program is now open for individuals seeking personalized addiction treatment. For more information about the program or DreamLife Recovery, please visitdreamliferecovery.com. For immediate addiction treatment assistance, please contact DreamLife Recovery admissions at 412-744-3928.

ABOUT DREAMLIFE RECOVERY

DreamLife Recovery is a Pennsylvania-based, clinician-owned center that provides trauma-informed, comprehensive treatment for alcohol and drug addiction. With a focus on treating the whole person with the medically appropriate care they need, DreamLife Recovery offers integrated programs to serve the needs of each individual patient, from dual diagnosis and trauma-informed care to treat co-occurring disorders, to specialized LGBTQIA+ programs and LIFEOffice programs designed to encourage working professionals to seek the recovery care they need. DreamLife Recovery comprises the flagship residential treatment center in Donegal, Pennsylvania; a partial hospitalization program in Pittsburgh; and a treatment center in Asheville, North Carolina, through partnership with Crest View Recovery Center. For more information on the facilities and treatment programs, visit dreamliferecovery.com

Media Contact
Bolt PR, DreamLife Recovery, 1 (949) 995-1459, dreamlife@boltpr.com

SOURCE DreamLife Recovery